nodes	percent_of_prediction	percent_of_DWPC	metapath
Ropinirole—CYP1A2—urine—urinary bladder cancer	0.00562	0.0928	CbGeAlD
Ropinirole—HTR2A—urine—urinary bladder cancer	0.0044	0.0726	CbGeAlD
Ropinirole—CYP3A4—urine—urinary bladder cancer	0.00407	0.0672	CbGeAlD
Ropinirole—CYP2D6—urine—urinary bladder cancer	0.00401	0.0661	CbGeAlD
Ropinirole—DRD5—female reproductive system—urinary bladder cancer	0.00289	0.0478	CbGeAlD
Ropinirole—ADRA2C—prostate gland—urinary bladder cancer	0.00233	0.0384	CbGeAlD
Ropinirole—HTR2B—smooth muscle tissue—urinary bladder cancer	0.00209	0.0345	CbGeAlD
Ropinirole—ADRA2C—seminal vesicle—urinary bladder cancer	0.00197	0.0325	CbGeAlD
Ropinirole—ADRA2A—prostate gland—urinary bladder cancer	0.00186	0.0306	CbGeAlD
Ropinirole—HTR1A—renal system—urinary bladder cancer	0.00181	0.0298	CbGeAlD
Ropinirole—HTR1B—female reproductive system—urinary bladder cancer	0.00179	0.0296	CbGeAlD
Ropinirole—HTR1D—female reproductive system—urinary bladder cancer	0.00173	0.0286	CbGeAlD
Ropinirole—HTR2C—female reproductive system—urinary bladder cancer	0.00172	0.0283	CbGeAlD
Ropinirole—HTR2B—female reproductive system—urinary bladder cancer	0.00161	0.0266	CbGeAlD
Ropinirole—ADRA2C—renal system—urinary bladder cancer	0.00159	0.0262	CbGeAlD
Ropinirole—ADRA2A—seminal vesicle—urinary bladder cancer	0.00157	0.0259	CbGeAlD
Ropinirole—ADRA2C—urethra—urinary bladder cancer	0.00156	0.0257	CbGeAlD
Ropinirole—HTR2B—vagina—urinary bladder cancer	0.00146	0.0241	CbGeAlD
Ropinirole—CYP1A2—renal system—urinary bladder cancer	0.00138	0.0227	CbGeAlD
Ropinirole—ADRA2A—urethra—urinary bladder cancer	0.00124	0.0205	CbGeAlD
Ropinirole—HTR2A—epithelium—urinary bladder cancer	0.00116	0.0191	CbGeAlD
Ropinirole—ADRA2C—vagina—urinary bladder cancer	0.00115	0.019	CbGeAlD
Ropinirole—HTR2A—smooth muscle tissue—urinary bladder cancer	0.00112	0.0184	CbGeAlD
Ropinirole—HTR2A—renal system—urinary bladder cancer	0.00108	0.0178	CbGeAlD
Ropinirole—ADRA2A—female reproductive system—urinary bladder cancer	0.00101	0.0167	CbGeAlD
Ropinirole—CYP3A4—renal system—urinary bladder cancer	0.000996	0.0164	CbGeAlD
Ropinirole—CYP2D6—renal system—urinary bladder cancer	0.00098	0.0162	CbGeAlD
Ropinirole—HTR2B—lymph node—urinary bladder cancer	0.000944	0.0156	CbGeAlD
Ropinirole—ADRA2A—vagina—urinary bladder cancer	0.000916	0.0151	CbGeAlD
Ropinirole—HTR2A—female reproductive system—urinary bladder cancer	0.000862	0.0142	CbGeAlD
Ropinirole—CYP3A4—female reproductive system—urinary bladder cancer	0.000798	0.0132	CbGeAlD
Ropinirole—CYP2D6—female reproductive system—urinary bladder cancer	0.000785	0.013	CbGeAlD
Ropinirole—HTR2A—vagina—urinary bladder cancer	0.000779	0.0129	CbGeAlD
Ropinirole—ADRA2C—lymph node—urinary bladder cancer	0.000743	0.0123	CbGeAlD
Ropinirole—ADRA2A—lymph node—urinary bladder cancer	0.000593	0.00978	CbGeAlD
Ropinirole—Haematuria—Doxorubicin—urinary bladder cancer	0.000253	0.000288	CcSEcCtD
Ropinirole—Connective tissue disorder—Epirubicin—urinary bladder cancer	0.000253	0.000288	CcSEcCtD
Ropinirole—Urethral disorder—Epirubicin—urinary bladder cancer	0.000253	0.000287	CcSEcCtD
Ropinirole—Hepatobiliary disease—Doxorubicin—urinary bladder cancer	0.000251	0.000286	CcSEcCtD
Ropinirole—Epistaxis—Doxorubicin—urinary bladder cancer	0.000251	0.000285	CcSEcCtD
Ropinirole—Angiopathy—Methotrexate—urinary bladder cancer	0.00025	0.000284	CcSEcCtD
Ropinirole—Sinusitis—Doxorubicin—urinary bladder cancer	0.000249	0.000283	CcSEcCtD
Ropinirole—Immune system disorder—Methotrexate—urinary bladder cancer	0.000249	0.000283	CcSEcCtD
Ropinirole—Dizziness—Fluorouracil—urinary bladder cancer	0.000249	0.000283	CcSEcCtD
Ropinirole—Visual impairment—Epirubicin—urinary bladder cancer	0.000248	0.000282	CcSEcCtD
Ropinirole—Mediastinal disorder—Methotrexate—urinary bladder cancer	0.000248	0.000282	CcSEcCtD
Ropinirole—Agranulocytosis—Doxorubicin—urinary bladder cancer	0.000248	0.000282	CcSEcCtD
Ropinirole—Chills—Methotrexate—urinary bladder cancer	0.000247	0.000281	CcSEcCtD
Ropinirole—Diarrhoea—Cisplatin—urinary bladder cancer	0.000244	0.000277	CcSEcCtD
Ropinirole—Alopecia—Methotrexate—urinary bladder cancer	0.000243	0.000277	CcSEcCtD
Ropinirole—Vomiting—Gemcitabine—urinary bladder cancer	0.000243	0.000277	CcSEcCtD
Ropinirole—Bradycardia—Doxorubicin—urinary bladder cancer	0.000243	0.000276	CcSEcCtD
Ropinirole—Mental disorder—Methotrexate—urinary bladder cancer	0.000241	0.000274	CcSEcCtD
Ropinirole—Rash—Gemcitabine—urinary bladder cancer	0.000241	0.000274	CcSEcCtD
Ropinirole—Dermatitis—Gemcitabine—urinary bladder cancer	0.000241	0.000274	CcSEcCtD
Ropinirole—Eye disorder—Epirubicin—urinary bladder cancer	0.000241	0.000274	CcSEcCtD
Ropinirole—Hypersensitivity—Etoposide—urinary bladder cancer	0.000241	0.000274	CcSEcCtD
Ropinirole—Tinnitus—Epirubicin—urinary bladder cancer	0.00024	0.000273	CcSEcCtD
Ropinirole—Malnutrition—Methotrexate—urinary bladder cancer	0.00024	0.000273	CcSEcCtD
Ropinirole—Haemoglobin—Doxorubicin—urinary bladder cancer	0.00024	0.000273	CcSEcCtD
Ropinirole—Headache—Gemcitabine—urinary bladder cancer	0.00024	0.000273	CcSEcCtD
Ropinirole—Cardiac disorder—Epirubicin—urinary bladder cancer	0.000239	0.000272	CcSEcCtD
Ropinirole—Flushing—Epirubicin—urinary bladder cancer	0.000239	0.000272	CcSEcCtD
Ropinirole—Vomiting—Fluorouracil—urinary bladder cancer	0.000239	0.000272	CcSEcCtD
Ropinirole—Rhinitis—Doxorubicin—urinary bladder cancer	0.000239	0.000272	CcSEcCtD
Ropinirole—Haemorrhage—Doxorubicin—urinary bladder cancer	0.000239	0.000271	CcSEcCtD
Ropinirole—Hypoaesthesia—Doxorubicin—urinary bladder cancer	0.000237	0.00027	CcSEcCtD
Ropinirole—Rash—Fluorouracil—urinary bladder cancer	0.000237	0.00027	CcSEcCtD
Ropinirole—Dermatitis—Fluorouracil—urinary bladder cancer	0.000237	0.000269	CcSEcCtD
Ropinirole—Pharyngitis—Doxorubicin—urinary bladder cancer	0.000237	0.000269	CcSEcCtD
Ropinirole—Headache—Fluorouracil—urinary bladder cancer	0.000236	0.000268	CcSEcCtD
Ropinirole—Urinary tract disorder—Doxorubicin—urinary bladder cancer	0.000236	0.000268	CcSEcCtD
Ropinirole—Oedema peripheral—Doxorubicin—urinary bladder cancer	0.000235	0.000267	CcSEcCtD
Ropinirole—Dysgeusia—Methotrexate—urinary bladder cancer	0.000235	0.000267	CcSEcCtD
Ropinirole—Asthenia—Etoposide—urinary bladder cancer	0.000234	0.000267	CcSEcCtD
Ropinirole—Connective tissue disorder—Doxorubicin—urinary bladder cancer	0.000234	0.000266	CcSEcCtD
Ropinirole—Angiopathy—Epirubicin—urinary bladder cancer	0.000234	0.000266	CcSEcCtD
Ropinirole—Urethral disorder—Doxorubicin—urinary bladder cancer	0.000234	0.000266	CcSEcCtD
Ropinirole—Immune system disorder—Epirubicin—urinary bladder cancer	0.000233	0.000265	CcSEcCtD
Ropinirole—Mediastinal disorder—Epirubicin—urinary bladder cancer	0.000232	0.000264	CcSEcCtD
Ropinirole—Back pain—Methotrexate—urinary bladder cancer	0.000232	0.000264	CcSEcCtD
Ropinirole—Chills—Epirubicin—urinary bladder cancer	0.000231	0.000263	CcSEcCtD
Ropinirole—Pruritus—Etoposide—urinary bladder cancer	0.000231	0.000263	CcSEcCtD
Ropinirole—Arrhythmia—Epirubicin—urinary bladder cancer	0.00023	0.000262	CcSEcCtD
Ropinirole—Visual impairment—Doxorubicin—urinary bladder cancer	0.00023	0.000261	CcSEcCtD
Ropinirole—Alopecia—Epirubicin—urinary bladder cancer	0.000228	0.000259	CcSEcCtD
Ropinirole—Nausea—Gemcitabine—urinary bladder cancer	0.000227	0.000258	CcSEcCtD
Ropinirole—Vomiting—Cisplatin—urinary bladder cancer	0.000227	0.000258	CcSEcCtD
Ropinirole—Vision blurred—Methotrexate—urinary bladder cancer	0.000226	0.000257	CcSEcCtD
Ropinirole—Mental disorder—Epirubicin—urinary bladder cancer	0.000226	0.000257	CcSEcCtD
Ropinirole—Rash—Cisplatin—urinary bladder cancer	0.000225	0.000256	CcSEcCtD
Ropinirole—Dermatitis—Cisplatin—urinary bladder cancer	0.000225	0.000255	CcSEcCtD
Ropinirole—Malnutrition—Epirubicin—urinary bladder cancer	0.000224	0.000255	CcSEcCtD
Ropinirole—Diarrhoea—Etoposide—urinary bladder cancer	0.000224	0.000254	CcSEcCtD
Ropinirole—Nausea—Fluorouracil—urinary bladder cancer	0.000223	0.000254	CcSEcCtD
Ropinirole—Eye disorder—Doxorubicin—urinary bladder cancer	0.000223	0.000253	CcSEcCtD
Ropinirole—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.000222	0.000253	CcSEcCtD
Ropinirole—Tinnitus—Doxorubicin—urinary bladder cancer	0.000222	0.000253	CcSEcCtD
Ropinirole—Anaemia—Methotrexate—urinary bladder cancer	0.000222	0.000252	CcSEcCtD
Ropinirole—Cardiac disorder—Doxorubicin—urinary bladder cancer	0.000221	0.000252	CcSEcCtD
Ropinirole—Flushing—Doxorubicin—urinary bladder cancer	0.000221	0.000252	CcSEcCtD
Ropinirole—Flatulence—Epirubicin—urinary bladder cancer	0.000221	0.000251	CcSEcCtD
Ropinirole—Tension—Epirubicin—urinary bladder cancer	0.00022	0.00025	CcSEcCtD
Ropinirole—Dysgeusia—Epirubicin—urinary bladder cancer	0.00022	0.00025	CcSEcCtD
Ropinirole—Nervousness—Epirubicin—urinary bladder cancer	0.000218	0.000248	CcSEcCtD
Ropinirole—Back pain—Epirubicin—urinary bladder cancer	0.000217	0.000247	CcSEcCtD
Ropinirole—Angiopathy—Doxorubicin—urinary bladder cancer	0.000216	0.000246	CcSEcCtD
Ropinirole—Malaise—Methotrexate—urinary bladder cancer	0.000216	0.000246	CcSEcCtD
Ropinirole—Dizziness—Etoposide—urinary bladder cancer	0.000216	0.000246	CcSEcCtD
Ropinirole—Muscle spasms—Epirubicin—urinary bladder cancer	0.000216	0.000245	CcSEcCtD
Ropinirole—Immune system disorder—Doxorubicin—urinary bladder cancer	0.000215	0.000245	CcSEcCtD
Ropinirole—Vertigo—Methotrexate—urinary bladder cancer	0.000215	0.000245	CcSEcCtD
Ropinirole—Mediastinal disorder—Doxorubicin—urinary bladder cancer	0.000215	0.000244	CcSEcCtD
Ropinirole—Leukopenia—Methotrexate—urinary bladder cancer	0.000215	0.000244	CcSEcCtD
Ropinirole—Chills—Doxorubicin—urinary bladder cancer	0.000214	0.000243	CcSEcCtD
Ropinirole—Arrhythmia—Doxorubicin—urinary bladder cancer	0.000213	0.000242	CcSEcCtD
Ropinirole—Nausea—Cisplatin—urinary bladder cancer	0.000212	0.000241	CcSEcCtD
Ropinirole—Vision blurred—Epirubicin—urinary bladder cancer	0.000211	0.00024	CcSEcCtD
Ropinirole—Alopecia—Doxorubicin—urinary bladder cancer	0.000211	0.00024	CcSEcCtD
Ropinirole—Cough—Methotrexate—urinary bladder cancer	0.000209	0.000238	CcSEcCtD
Ropinirole—Mental disorder—Doxorubicin—urinary bladder cancer	0.000209	0.000238	CcSEcCtD
Ropinirole—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.000208	0.000237	CcSEcCtD
Ropinirole—Convulsion—Methotrexate—urinary bladder cancer	0.000208	0.000236	CcSEcCtD
Ropinirole—Vomiting—Etoposide—urinary bladder cancer	0.000208	0.000236	CcSEcCtD
Ropinirole—Malnutrition—Doxorubicin—urinary bladder cancer	0.000208	0.000236	CcSEcCtD
Ropinirole—Anaemia—Epirubicin—urinary bladder cancer	0.000207	0.000236	CcSEcCtD
Ropinirole—Agitation—Epirubicin—urinary bladder cancer	0.000206	0.000234	CcSEcCtD
Ropinirole—Rash—Etoposide—urinary bladder cancer	0.000206	0.000234	CcSEcCtD
Ropinirole—Dermatitis—Etoposide—urinary bladder cancer	0.000206	0.000234	CcSEcCtD
Ropinirole—Headache—Etoposide—urinary bladder cancer	0.000205	0.000233	CcSEcCtD
Ropinirole—Flatulence—Doxorubicin—urinary bladder cancer	0.000205	0.000233	CcSEcCtD
Ropinirole—Arthralgia—Methotrexate—urinary bladder cancer	0.000204	0.000232	CcSEcCtD
Ropinirole—Myalgia—Methotrexate—urinary bladder cancer	0.000204	0.000232	CcSEcCtD
Ropinirole—Chest pain—Methotrexate—urinary bladder cancer	0.000204	0.000232	CcSEcCtD
Ropinirole—Tension—Doxorubicin—urinary bladder cancer	0.000204	0.000232	CcSEcCtD
Ropinirole—Dysgeusia—Doxorubicin—urinary bladder cancer	0.000203	0.000231	CcSEcCtD
Ropinirole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.000203	0.00023	CcSEcCtD
Ropinirole—Malaise—Epirubicin—urinary bladder cancer	0.000202	0.00023	CcSEcCtD
Ropinirole—Discomfort—Methotrexate—urinary bladder cancer	0.000202	0.000229	CcSEcCtD
Ropinirole—Nervousness—Doxorubicin—urinary bladder cancer	0.000202	0.000229	CcSEcCtD
Ropinirole—Vertigo—Epirubicin—urinary bladder cancer	0.000202	0.000229	CcSEcCtD
Ropinirole—Syncope—Epirubicin—urinary bladder cancer	0.000201	0.000229	CcSEcCtD
Ropinirole—Leukopenia—Epirubicin—urinary bladder cancer	0.000201	0.000228	CcSEcCtD
Ropinirole—Back pain—Doxorubicin—urinary bladder cancer	0.000201	0.000228	CcSEcCtD
Ropinirole—Muscle spasms—Doxorubicin—urinary bladder cancer	0.0002	0.000227	CcSEcCtD
Ropinirole—Palpitations—Epirubicin—urinary bladder cancer	0.000198	0.000225	CcSEcCtD
Ropinirole—Confusional state—Methotrexate—urinary bladder cancer	0.000197	0.000224	CcSEcCtD
Ropinirole—Loss of consciousness—Epirubicin—urinary bladder cancer	0.000197	0.000224	CcSEcCtD
Ropinirole—Cough—Epirubicin—urinary bladder cancer	0.000196	0.000223	CcSEcCtD
Ropinirole—Vision blurred—Doxorubicin—urinary bladder cancer	0.000196	0.000222	CcSEcCtD
Ropinirole—Convulsion—Epirubicin—urinary bladder cancer	0.000194	0.000221	CcSEcCtD
Ropinirole—Infection—Methotrexate—urinary bladder cancer	0.000194	0.000221	CcSEcCtD
Ropinirole—Nausea—Etoposide—urinary bladder cancer	0.000194	0.000221	CcSEcCtD
Ropinirole—Hypertension—Epirubicin—urinary bladder cancer	0.000194	0.00022	CcSEcCtD
Ropinirole—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.000193	0.000219	CcSEcCtD
Ropinirole—Nervous system disorder—Methotrexate—urinary bladder cancer	0.000192	0.000218	CcSEcCtD
Ropinirole—Anaemia—Doxorubicin—urinary bladder cancer	0.000192	0.000218	CcSEcCtD
Ropinirole—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.000192	0.000218	CcSEcCtD
Ropinirole—Chest pain—Epirubicin—urinary bladder cancer	0.000191	0.000217	CcSEcCtD
Ropinirole—Myalgia—Epirubicin—urinary bladder cancer	0.000191	0.000217	CcSEcCtD
Ropinirole—Arthralgia—Epirubicin—urinary bladder cancer	0.000191	0.000217	CcSEcCtD
Ropinirole—Agitation—Doxorubicin—urinary bladder cancer	0.000191	0.000217	CcSEcCtD
Ropinirole—Anxiety—Epirubicin—urinary bladder cancer	0.00019	0.000216	CcSEcCtD
Ropinirole—Skin disorder—Methotrexate—urinary bladder cancer	0.00019	0.000216	CcSEcCtD
Ropinirole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.00019	0.000216	CcSEcCtD
Ropinirole—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000189	0.000215	CcSEcCtD
Ropinirole—Discomfort—Epirubicin—urinary bladder cancer	0.000189	0.000215	CcSEcCtD
Ropinirole—Malaise—Doxorubicin—urinary bladder cancer	0.000187	0.000213	CcSEcCtD
Ropinirole—Dry mouth—Epirubicin—urinary bladder cancer	0.000187	0.000212	CcSEcCtD
Ropinirole—Vertigo—Doxorubicin—urinary bladder cancer	0.000187	0.000212	CcSEcCtD
Ropinirole—Anorexia—Methotrexate—urinary bladder cancer	0.000187	0.000212	CcSEcCtD
Ropinirole—Syncope—Doxorubicin—urinary bladder cancer	0.000186	0.000212	CcSEcCtD
Ropinirole—Leukopenia—Doxorubicin—urinary bladder cancer	0.000186	0.000211	CcSEcCtD
Ropinirole—Confusional state—Epirubicin—urinary bladder cancer	0.000185	0.00021	CcSEcCtD
Ropinirole—Palpitations—Doxorubicin—urinary bladder cancer	0.000183	0.000209	CcSEcCtD
Ropinirole—Oedema—Epirubicin—urinary bladder cancer	0.000183	0.000208	CcSEcCtD
Ropinirole—Hypotension—Methotrexate—urinary bladder cancer	0.000183	0.000208	CcSEcCtD
Ropinirole—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.000182	0.000207	CcSEcCtD
Ropinirole—Infection—Epirubicin—urinary bladder cancer	0.000182	0.000207	CcSEcCtD
Ropinirole—Cough—Doxorubicin—urinary bladder cancer	0.000181	0.000206	CcSEcCtD
Ropinirole—Shock—Epirubicin—urinary bladder cancer	0.00018	0.000205	CcSEcCtD
Ropinirole—Convulsion—Doxorubicin—urinary bladder cancer	0.00018	0.000205	CcSEcCtD
Ropinirole—Nervous system disorder—Epirubicin—urinary bladder cancer	0.00018	0.000204	CcSEcCtD
Ropinirole—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000179	0.000204	CcSEcCtD
Ropinirole—Hypertension—Doxorubicin—urinary bladder cancer	0.000179	0.000204	CcSEcCtD
Ropinirole—Tachycardia—Epirubicin—urinary bladder cancer	0.000179	0.000203	CcSEcCtD
Ropinirole—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000178	0.000203	CcSEcCtD
Ropinirole—Skin disorder—Epirubicin—urinary bladder cancer	0.000178	0.000202	CcSEcCtD
Ropinirole—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000177	0.000201	CcSEcCtD
Ropinirole—Insomnia—Methotrexate—urinary bladder cancer	0.000177	0.000201	CcSEcCtD
Ropinirole—Chest pain—Doxorubicin—urinary bladder cancer	0.000177	0.000201	CcSEcCtD
Ropinirole—Myalgia—Doxorubicin—urinary bladder cancer	0.000177	0.000201	CcSEcCtD
Ropinirole—Arthralgia—Doxorubicin—urinary bladder cancer	0.000177	0.000201	CcSEcCtD
Ropinirole—Anxiety—Doxorubicin—urinary bladder cancer	0.000176	0.0002	CcSEcCtD
Ropinirole—Paraesthesia—Methotrexate—urinary bladder cancer	0.000176	0.0002	CcSEcCtD
Ropinirole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.000176	0.0002	CcSEcCtD
Ropinirole—Discomfort—Doxorubicin—urinary bladder cancer	0.000175	0.000199	CcSEcCtD
Ropinirole—Anorexia—Epirubicin—urinary bladder cancer	0.000175	0.000198	CcSEcCtD
Ropinirole—Dyspnoea—Methotrexate—urinary bladder cancer	0.000174	0.000198	CcSEcCtD
Ropinirole—Somnolence—Methotrexate—urinary bladder cancer	0.000174	0.000198	CcSEcCtD
Ropinirole—Dry mouth—Doxorubicin—urinary bladder cancer	0.000173	0.000197	CcSEcCtD
Ropinirole—Dyspepsia—Methotrexate—urinary bladder cancer	0.000172	0.000196	CcSEcCtD
Ropinirole—Hypotension—Epirubicin—urinary bladder cancer	0.000171	0.000195	CcSEcCtD
Ropinirole—Confusional state—Doxorubicin—urinary bladder cancer	0.000171	0.000194	CcSEcCtD
Ropinirole—Decreased appetite—Methotrexate—urinary bladder cancer	0.00017	0.000193	CcSEcCtD
Ropinirole—Oedema—Doxorubicin—urinary bladder cancer	0.000169	0.000193	CcSEcCtD
Ropinirole—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000169	0.000192	CcSEcCtD
Ropinirole—Fatigue—Methotrexate—urinary bladder cancer	0.000169	0.000192	CcSEcCtD
Ropinirole—Infection—Doxorubicin—urinary bladder cancer	0.000168	0.000191	CcSEcCtD
Ropinirole—Pain—Methotrexate—urinary bladder cancer	0.000167	0.00019	CcSEcCtD
Ropinirole—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000167	0.00019	CcSEcCtD
Ropinirole—Shock—Doxorubicin—urinary bladder cancer	0.000167	0.00019	CcSEcCtD
Ropinirole—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.000166	0.000189	CcSEcCtD
Ropinirole—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.000166	0.000189	CcSEcCtD
Ropinirole—Insomnia—Epirubicin—urinary bladder cancer	0.000166	0.000188	CcSEcCtD
Ropinirole—Tachycardia—Doxorubicin—urinary bladder cancer	0.000165	0.000188	CcSEcCtD
Ropinirole—Skin disorder—Doxorubicin—urinary bladder cancer	0.000165	0.000187	CcSEcCtD
Ropinirole—Paraesthesia—Epirubicin—urinary bladder cancer	0.000164	0.000187	CcSEcCtD
Ropinirole—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000164	0.000186	CcSEcCtD
Ropinirole—Dyspnoea—Epirubicin—urinary bladder cancer	0.000163	0.000186	CcSEcCtD
Ropinirole—Somnolence—Epirubicin—urinary bladder cancer	0.000163	0.000185	CcSEcCtD
Ropinirole—Anorexia—Doxorubicin—urinary bladder cancer	0.000162	0.000184	CcSEcCtD
Ropinirole—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000161	0.000183	CcSEcCtD
Ropinirole—Dyspepsia—Epirubicin—urinary bladder cancer	0.000161	0.000183	CcSEcCtD
Ropinirole—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.00016	0.000182	CcSEcCtD
Ropinirole—Decreased appetite—Epirubicin—urinary bladder cancer	0.000159	0.000181	CcSEcCtD
Ropinirole—Hypotension—Doxorubicin—urinary bladder cancer	0.000158	0.00018	CcSEcCtD
Ropinirole—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000158	0.00018	CcSEcCtD
Ropinirole—Fatigue—Epirubicin—urinary bladder cancer	0.000158	0.00018	CcSEcCtD
Ropinirole—Constipation—Epirubicin—urinary bladder cancer	0.000157	0.000178	CcSEcCtD
Ropinirole—Pain—Epirubicin—urinary bladder cancer	0.000157	0.000178	CcSEcCtD
Ropinirole—Urticaria—Methotrexate—urinary bladder cancer	0.000155	0.000177	CcSEcCtD
Ropinirole—Abdominal pain—Methotrexate—urinary bladder cancer	0.000155	0.000176	CcSEcCtD
Ropinirole—Body temperature increased—Methotrexate—urinary bladder cancer	0.000155	0.000176	CcSEcCtD
Ropinirole—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000154	0.000176	CcSEcCtD
Ropinirole—Insomnia—Doxorubicin—urinary bladder cancer	0.000153	0.000174	CcSEcCtD
Ropinirole—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000152	0.000173	CcSEcCtD
Ropinirole—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000151	0.000172	CcSEcCtD
Ropinirole—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000151	0.000172	CcSEcCtD
Ropinirole—Somnolence—Doxorubicin—urinary bladder cancer	0.000151	0.000171	CcSEcCtD
Ropinirole—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.00015	0.00017	CcSEcCtD
Ropinirole—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000149	0.00017	CcSEcCtD
Ropinirole—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000147	0.000167	CcSEcCtD
Ropinirole—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000146	0.000166	CcSEcCtD
Ropinirole—Fatigue—Doxorubicin—urinary bladder cancer	0.000146	0.000166	CcSEcCtD
Ropinirole—Urticaria—Epirubicin—urinary bladder cancer	0.000145	0.000165	CcSEcCtD
Ropinirole—Pain—Doxorubicin—urinary bladder cancer	0.000145	0.000165	CcSEcCtD
Ropinirole—Constipation—Doxorubicin—urinary bladder cancer	0.000145	0.000165	CcSEcCtD
Ropinirole—Abdominal pain—Epirubicin—urinary bladder cancer	0.000145	0.000165	CcSEcCtD
Ropinirole—Body temperature increased—Epirubicin—urinary bladder cancer	0.000145	0.000165	CcSEcCtD
Ropinirole—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000144	0.000164	CcSEcCtD
Ropinirole—Asthenia—Methotrexate—urinary bladder cancer	0.00014	0.00016	CcSEcCtD
Ropinirole—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.00014	0.000159	CcSEcCtD
Ropinirole—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000139	0.000158	CcSEcCtD
Ropinirole—Pruritus—Methotrexate—urinary bladder cancer	0.000138	0.000157	CcSEcCtD
Ropinirole—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000135	0.000153	CcSEcCtD
Ropinirole—Urticaria—Doxorubicin—urinary bladder cancer	0.000135	0.000153	CcSEcCtD
Ropinirole—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000134	0.000152	CcSEcCtD
Ropinirole—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000134	0.000152	CcSEcCtD
Ropinirole—Diarrhoea—Methotrexate—urinary bladder cancer	0.000134	0.000152	CcSEcCtD
Ropinirole—Asthenia—Epirubicin—urinary bladder cancer	0.000131	0.000149	CcSEcCtD
Ropinirole—Pruritus—Epirubicin—urinary bladder cancer	0.00013	0.000147	CcSEcCtD
Ropinirole—Dizziness—Methotrexate—urinary bladder cancer	0.000129	0.000147	CcSEcCtD
Ropinirole—Diarrhoea—Epirubicin—urinary bladder cancer	0.000125	0.000142	CcSEcCtD
Ropinirole—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000125	0.000142	CcSEcCtD
Ropinirole—Vomiting—Methotrexate—urinary bladder cancer	0.000124	0.000141	CcSEcCtD
Ropinirole—Rash—Methotrexate—urinary bladder cancer	0.000123	0.00014	CcSEcCtD
Ropinirole—Dermatitis—Methotrexate—urinary bladder cancer	0.000123	0.00014	CcSEcCtD
Ropinirole—Headache—Methotrexate—urinary bladder cancer	0.000123	0.000139	CcSEcCtD
Ropinirole—Asthenia—Doxorubicin—urinary bladder cancer	0.000122	0.000138	CcSEcCtD
Ropinirole—Dizziness—Epirubicin—urinary bladder cancer	0.000121	0.000138	CcSEcCtD
Ropinirole—Pruritus—Doxorubicin—urinary bladder cancer	0.00012	0.000136	CcSEcCtD
Ropinirole—Vomiting—Epirubicin—urinary bladder cancer	0.000116	0.000132	CcSEcCtD
Ropinirole—Nausea—Methotrexate—urinary bladder cancer	0.000116	0.000132	CcSEcCtD
Ropinirole—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000116	0.000132	CcSEcCtD
Ropinirole—Rash—Epirubicin—urinary bladder cancer	0.000115	0.000131	CcSEcCtD
Ropinirole—Dermatitis—Epirubicin—urinary bladder cancer	0.000115	0.000131	CcSEcCtD
Ropinirole—Headache—Epirubicin—urinary bladder cancer	0.000115	0.00013	CcSEcCtD
Ropinirole—Dizziness—Doxorubicin—urinary bladder cancer	0.000112	0.000127	CcSEcCtD
Ropinirole—Nausea—Epirubicin—urinary bladder cancer	0.000109	0.000124	CcSEcCtD
Ropinirole—Vomiting—Doxorubicin—urinary bladder cancer	0.000108	0.000122	CcSEcCtD
Ropinirole—Rash—Doxorubicin—urinary bladder cancer	0.000107	0.000121	CcSEcCtD
Ropinirole—Dermatitis—Doxorubicin—urinary bladder cancer	0.000107	0.000121	CcSEcCtD
Ropinirole—Headache—Doxorubicin—urinary bladder cancer	0.000106	0.000121	CcSEcCtD
Ropinirole—Nausea—Doxorubicin—urinary bladder cancer	0.000101	0.000114	CcSEcCtD
Ropinirole—DRD4—Signaling Pathways—CCND1—urinary bladder cancer	1.22e-05	0.000203	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—IGF1—urinary bladder cancer	1.22e-05	0.000203	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.21e-05	0.000203	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling by GPCR—EGFR—urinary bladder cancer	1.21e-05	0.000202	CbGpPWpGaD
Ropinirole—ADRA2C—Metabolism—PTGS2—urinary bladder cancer	1.2e-05	0.000201	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—MMP9—urinary bladder cancer	1.2e-05	0.0002	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	1.2e-05	0.0002	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—ENO2—urinary bladder cancer	1.2e-05	0.0002	CbGpPWpGaD
Ropinirole—ADRA2A—Metabolism—CREBBP—urinary bladder cancer	1.2e-05	0.0002	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—CDKN1A—urinary bladder cancer	1.19e-05	0.0002	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—PTEN—urinary bladder cancer	1.19e-05	0.000199	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—RHOA—urinary bladder cancer	1.19e-05	0.000199	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—IL2—urinary bladder cancer	1.19e-05	0.000199	CbGpPWpGaD
Ropinirole—HTR1A—Signaling by GPCR—KRAS—urinary bladder cancer	1.18e-05	0.000197	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—MMP9—urinary bladder cancer	1.18e-05	0.000197	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—CDKN1A—urinary bladder cancer	1.18e-05	0.000197	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—CXCL8—urinary bladder cancer	1.17e-05	0.000196	CbGpPWpGaD
Ropinirole—HTR2C—Signaling by GPCR—KRAS—urinary bladder cancer	1.17e-05	0.000196	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—FGFR3—urinary bladder cancer	1.17e-05	0.000196	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—PTEN—urinary bladder cancer	1.17e-05	0.000196	CbGpPWpGaD
Ropinirole—DRD1—Signaling by GPCR—HRAS—urinary bladder cancer	1.17e-05	0.000195	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	1.16e-05	0.000194	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—EP300—urinary bladder cancer	1.16e-05	0.000194	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—CCND1—urinary bladder cancer	1.16e-05	0.000194	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—CXCL8—urinary bladder cancer	1.16e-05	0.000194	CbGpPWpGaD
Ropinirole—DRD3—Signaling by GPCR—HRAS—urinary bladder cancer	1.15e-05	0.000192	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—RHOA—urinary bladder cancer	1.15e-05	0.000192	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—TYMS—urinary bladder cancer	1.14e-05	0.000191	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—RHOA—urinary bladder cancer	1.14e-05	0.000191	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling by GPCR—KRAS—urinary bladder cancer	1.14e-05	0.000191	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—ESR1—urinary bladder cancer	1.14e-05	0.000191	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—EP300—urinary bladder cancer	1.14e-05	0.00019	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—GSTM1—urinary bladder cancer	1.13e-05	0.000189	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—NCOR1—urinary bladder cancer	1.13e-05	0.000189	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—SRC—urinary bladder cancer	1.13e-05	0.000189	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—MMP9—urinary bladder cancer	1.13e-05	0.000188	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—IL2—urinary bladder cancer	1.12e-05	0.000188	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—CDKN1A—urinary bladder cancer	1.12e-05	0.000188	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—PTEN—urinary bladder cancer	1.12e-05	0.000187	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—EP300—urinary bladder cancer	1.12e-05	0.000187	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—CREBBP—urinary bladder cancer	1.12e-05	0.000187	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—RHOA—urinary bladder cancer	1.11e-05	0.000186	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—IL2—urinary bladder cancer	1.11e-05	0.000185	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—SRC—urinary bladder cancer	1.11e-05	0.000185	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—ERBB2—urinary bladder cancer	1.1e-05	0.000184	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—IGF1—urinary bladder cancer	1.1e-05	0.000184	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—CREBBP—urinary bladder cancer	1.1e-05	0.000184	CbGpPWpGaD
Ropinirole—DRD2—Signaling by GPCR—EGFR—urinary bladder cancer	1.1e-05	0.000183	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—CCND1—urinary bladder cancer	1.09e-05	0.000183	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—SRC—urinary bladder cancer	1.09e-05	0.000182	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—IGF1—urinary bladder cancer	1.08e-05	0.000181	CbGpPWpGaD
Ropinirole—DRD5—Signaling Pathways—TP53—urinary bladder cancer	1.08e-05	0.000181	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—GPX1—urinary bladder cancer	1.08e-05	0.000181	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—CCND1—urinary bladder cancer	1.08e-05	0.00018	CbGpPWpGaD
Ropinirole—HTR2A—Signaling by GPCR—EGFR—urinary bladder cancer	1.08e-05	0.00018	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—EP300—urinary bladder cancer	1.07e-05	0.000179	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—ERBB2—urinary bladder cancer	1.06e-05	0.000178	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—ERCC2—urinary bladder cancer	1.06e-05	0.000178	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—MMP9—urinary bladder cancer	1.06e-05	0.000178	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—ERBB2—urinary bladder cancer	1.06e-05	0.000177	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—CDKN1A—urinary bladder cancer	1.06e-05	0.000177	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.06e-05	0.000177	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—PTEN—urinary bladder cancer	1.06e-05	0.000177	CbGpPWpGaD
Ropinirole—ADRA2C—Metabolism—PTEN—urinary bladder cancer	1.05e-05	0.000176	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—MMP9—urinary bladder cancer	1.05e-05	0.000175	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—CXCL8—urinary bladder cancer	1.05e-05	0.000175	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—CDKN1A—urinary bladder cancer	1.04e-05	0.000175	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—GSTP1—urinary bladder cancer	1.04e-05	0.000174	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—PTEN—urinary bladder cancer	1.04e-05	0.000174	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling by GPCR—HRAS—urinary bladder cancer	1.04e-05	0.000174	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—SRC—urinary bladder cancer	1.04e-05	0.000174	CbGpPWpGaD
Ropinirole—DRD5—Signaling Pathways—HRAS—urinary bladder cancer	1.04e-05	0.000173	CbGpPWpGaD
Ropinirole—DRD2—Signaling by GPCR—KRAS—urinary bladder cancer	1.04e-05	0.000173	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—ERBB2—urinary bladder cancer	1.03e-05	0.000172	CbGpPWpGaD
Ropinirole—HTR2A—Signaling by GPCR—KRAS—urinary bladder cancer	1.02e-05	0.00017	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—MYC—urinary bladder cancer	1.01e-05	0.000169	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—RHOA—urinary bladder cancer	1.01e-05	0.000169	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—CXCL8—urinary bladder cancer	1.01e-05	0.000169	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.01e-05	0.000169	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—EP300—urinary bladder cancer	1.01e-05	0.000168	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—CXCL8—urinary bladder cancer	1e-05	0.000168	CbGpPWpGaD
Ropinirole—HTR1A—Signaling by GPCR—HRAS—urinary bladder cancer	1e-05	0.000168	CbGpPWpGaD
Ropinirole—ADRA2C—Metabolism—EP300—urinary bladder cancer	1e-05	0.000168	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—MTHFR—urinary bladder cancer	1e-05	0.000167	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—IL2—urinary bladder cancer	1e-05	0.000167	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—CREBBP—urinary bladder cancer	9.99e-06	0.000167	CbGpPWpGaD
Ropinirole—HTR2C—Signaling by GPCR—HRAS—urinary bladder cancer	9.98e-06	0.000167	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—RHOA—urinary bladder cancer	9.94e-06	0.000166	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—EP300—urinary bladder cancer	9.94e-06	0.000166	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—MYC—urinary bladder cancer	9.91e-06	0.000166	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—EGFR—urinary bladder cancer	9.9e-06	0.000165	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—IGF1—urinary bladder cancer	9.87e-06	0.000165	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling by GPCR—EGFR—urinary bladder cancer	9.82e-06	0.000164	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—SRC—urinary bladder cancer	9.79e-06	0.000164	CbGpPWpGaD
Ropinirole—ADRA2A—Metabolism—PTGS2—urinary bladder cancer	9.79e-06	0.000164	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—CXCL8—urinary bladder cancer	9.77e-06	0.000163	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—MYC—urinary bladder cancer	9.75e-06	0.000163	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—CCND1—urinary bladder cancer	9.75e-06	0.000163	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling by GPCR—HRAS—urinary bladder cancer	9.71e-06	0.000162	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—TYMS—urinary bladder cancer	9.7e-06	0.000162	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—EGFR—urinary bladder cancer	9.69e-06	0.000162	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—SRC—urinary bladder cancer	9.66e-06	0.000162	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—IL2—urinary bladder cancer	9.65e-06	0.000161	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—NQO1—urinary bladder cancer	9.65e-06	0.000161	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—IL2—urinary bladder cancer	9.6e-06	0.000161	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—NCOR1—urinary bladder cancer	9.58e-06	0.00016	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—GSTM1—urinary bladder cancer	9.58e-06	0.00016	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—EGFR—urinary bladder cancer	9.53e-06	0.000159	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—MMP9—urinary bladder cancer	9.46e-06	0.000158	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—CDKN1A—urinary bladder cancer	9.43e-06	0.000158	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—CCND1—urinary bladder cancer	9.41e-06	0.000157	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—PTEN—urinary bladder cancer	9.41e-06	0.000157	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—CCND1—urinary bladder cancer	9.36e-06	0.000156	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—ERBB2—urinary bladder cancer	9.35e-06	0.000156	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—KRAS—urinary bladder cancer	9.35e-06	0.000156	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—IL2—urinary bladder cancer	9.34e-06	0.000156	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—MYC—urinary bladder cancer	9.31e-06	0.000156	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling by GPCR—KRAS—urinary bladder cancer	9.28e-06	0.000155	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—ERBB2—urinary bladder cancer	9.2e-06	0.000154	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—GPX1—urinary bladder cancer	9.18e-06	0.000153	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—KRAS—urinary bladder cancer	9.15e-06	0.000153	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—MMP9—urinary bladder cancer	9.13e-06	0.000153	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—CCND1—urinary bladder cancer	9.1e-06	0.000152	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—EGFR—urinary bladder cancer	9.1e-06	0.000152	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—CDKN1A—urinary bladder cancer	9.1e-06	0.000152	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—MMP9—urinary bladder cancer	9.09e-06	0.000152	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—PTEN—urinary bladder cancer	9.08e-06	0.000152	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—CDKN1A—urinary bladder cancer	9.05e-06	0.000151	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—RHOA—urinary bladder cancer	9.04e-06	0.000151	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—PTEN—urinary bladder cancer	9.03e-06	0.000151	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—ERCC2—urinary bladder cancer	9.01e-06	0.000151	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—KRAS—urinary bladder cancer	9.01e-06	0.000151	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—EP300—urinary bladder cancer	8.97e-06	0.00015	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—CXCL8—urinary bladder cancer	8.87e-06	0.000148	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—MMP9—urinary bladder cancer	8.84e-06	0.000148	CbGpPWpGaD
Ropinirole—DRD2—Signaling by GPCR—HRAS—urinary bladder cancer	8.81e-06	0.000147	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—CDKN1A—urinary bladder cancer	8.81e-06	0.000147	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—PTEN—urinary bladder cancer	8.79e-06	0.000147	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—MYC—urinary bladder cancer	8.78e-06	0.000147	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—CXCL8—urinary bladder cancer	8.72e-06	0.000146	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—SRC—urinary bladder cancer	8.72e-06	0.000146	CbGpPWpGaD
Ropinirole—HTR2A—Signaling by GPCR—HRAS—urinary bladder cancer	8.67e-06	0.000145	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—EP300—urinary bladder cancer	8.66e-06	0.000145	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—MYC—urinary bladder cancer	8.66e-06	0.000145	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—EP300—urinary bladder cancer	8.62e-06	0.000144	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—KRAS—urinary bladder cancer	8.6e-06	0.000144	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—EGFR—urinary bladder cancer	8.58e-06	0.000143	CbGpPWpGaD
Ropinirole—ADRA2A—Metabolism—PTEN—urinary bladder cancer	8.54e-06	0.000143	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—IL2—urinary bladder cancer	8.47e-06	0.000142	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—MTHFR—urinary bladder cancer	8.47e-06	0.000142	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—EGFR—urinary bladder cancer	8.47e-06	0.000142	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—SRC—urinary bladder cancer	8.42e-06	0.000141	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—EP300—urinary bladder cancer	8.38e-06	0.00014	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—SRC—urinary bladder cancer	8.38e-06	0.00014	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—ERBB2—urinary bladder cancer	8.37e-06	0.00014	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—IL2—urinary bladder cancer	8.34e-06	0.000139	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—TP53—urinary bladder cancer	8.31e-06	0.000139	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—CCND1—urinary bladder cancer	8.26e-06	0.000138	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—SRC—urinary bladder cancer	8.15e-06	0.000136	CbGpPWpGaD
Ropinirole—ADRA2A—Metabolism—EP300—urinary bladder cancer	8.14e-06	0.000136	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—TP53—urinary bladder cancer	8.14e-06	0.000136	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—CCND1—urinary bladder cancer	8.13e-06	0.000136	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—KRAS—urinary bladder cancer	8.11e-06	0.000136	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—PPARG—urinary bladder cancer	8.11e-06	0.000136	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	8.05e-06	0.000135	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—MMP9—urinary bladder cancer	8.02e-06	0.000134	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—TP53—urinary bladder cancer	8.01e-06	0.000134	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—KRAS—urinary bladder cancer	8e-06	0.000134	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—CDKN1A—urinary bladder cancer	7.99e-06	0.000134	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—PTEN—urinary bladder cancer	7.97e-06	0.000133	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—HRAS—urinary bladder cancer	7.95e-06	0.000133	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—CXCL8—urinary bladder cancer	7.94e-06	0.000133	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—MMP9—urinary bladder cancer	7.89e-06	0.000132	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling by GPCR—HRAS—urinary bladder cancer	7.89e-06	0.000132	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—CDKN1A—urinary bladder cancer	7.86e-06	0.000131	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—PTEN—urinary bladder cancer	7.84e-06	0.000131	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—MYC—urinary bladder cancer	7.82e-06	0.000131	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—CREBBP—urinary bladder cancer	7.79e-06	0.00013	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—HRAS—urinary bladder cancer	7.78e-06	0.00013	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—HRAS—urinary bladder cancer	7.66e-06	0.000128	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—EGFR—urinary bladder cancer	7.65e-06	0.000128	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—TP53—urinary bladder cancer	7.64e-06	0.000128	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—EP300—urinary bladder cancer	7.6e-06	0.000127	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—IL2—urinary bladder cancer	7.59e-06	0.000127	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—MYC—urinary bladder cancer	7.55e-06	0.000126	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—MYC—urinary bladder cancer	7.51e-06	0.000126	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—TYMS—urinary bladder cancer	7.48e-06	0.000125	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—EP300—urinary bladder cancer	7.48e-06	0.000125	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	7.4e-06	0.000124	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	7.4e-06	0.000124	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—CCND1—urinary bladder cancer	7.39e-06	0.000124	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—SRC—urinary bladder cancer	7.39e-06	0.000124	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—EGFR—urinary bladder cancer	7.38e-06	0.000123	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—EGFR—urinary bladder cancer	7.34e-06	0.000123	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—HRAS—urinary bladder cancer	7.31e-06	0.000122	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—MYC—urinary bladder cancer	7.3e-06	0.000122	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—SRC—urinary bladder cancer	7.28e-06	0.000122	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—KRAS—urinary bladder cancer	7.22e-06	0.000121	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—TP53—urinary bladder cancer	7.21e-06	0.00012	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—MMP9—urinary bladder cancer	7.18e-06	0.00012	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—CDKN1A—urinary bladder cancer	7.15e-06	0.00012	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—EGFR—urinary bladder cancer	7.14e-06	0.000119	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—PTEN—urinary bladder cancer	7.14e-06	0.000119	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—TP53—urinary bladder cancer	7.11e-06	0.000119	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—GPX1—urinary bladder cancer	7.08e-06	0.000118	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—KRAS—urinary bladder cancer	6.97e-06	0.000117	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	6.95e-06	0.000116	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—KRAS—urinary bladder cancer	6.94e-06	0.000116	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—HRAS—urinary bladder cancer	6.89e-06	0.000115	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—PPARG—urinary bladder cancer	6.87e-06	0.000115	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—EP300—urinary bladder cancer	6.81e-06	0.000114	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—HRAS—urinary bladder cancer	6.8e-06	0.000114	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—KRAS—urinary bladder cancer	6.75e-06	0.000113	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—MYC—urinary bladder cancer	6.63e-06	0.000111	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—SRC—urinary bladder cancer	6.62e-06	0.000111	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—CREBBP—urinary bladder cancer	6.6e-06	0.00011	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	6.54e-06	0.000109	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—MYC—urinary bladder cancer	6.52e-06	0.000109	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—EGFR—urinary bladder cancer	6.48e-06	0.000108	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—TP53—urinary bladder cancer	6.42e-06	0.000107	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—PTGS2—urinary bladder cancer	6.38e-06	0.000107	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—EGFR—urinary bladder cancer	6.38e-06	0.000107	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—TP53—urinary bladder cancer	6.2e-06	0.000104	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—TP53—urinary bladder cancer	6.17e-06	0.000103	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—HRAS—urinary bladder cancer	6.14e-06	0.000103	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—KRAS—urinary bladder cancer	6.12e-06	0.000102	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—KRAS—urinary bladder cancer	6.02e-06	0.000101	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—TP53—urinary bladder cancer	6e-06	0.0001	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—MYC—urinary bladder cancer	5.93e-06	9.92e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—HRAS—urinary bladder cancer	5.93e-06	9.91e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—HRAS—urinary bladder cancer	5.9e-06	9.86e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—EGFR—urinary bladder cancer	5.8e-06	9.7e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—HRAS—urinary bladder cancer	5.74e-06	9.59e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—PTEN—urinary bladder cancer	5.56e-06	9.3e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—KRAS—urinary bladder cancer	5.48e-06	9.16e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—TP53—urinary bladder cancer	5.44e-06	9.1e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—PTGS2—urinary bladder cancer	5.4e-06	9.03e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—TP53—urinary bladder cancer	5.35e-06	8.95e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—EP300—urinary bladder cancer	5.3e-06	8.87e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—PPARG—urinary bladder cancer	5.3e-06	8.86e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—HRAS—urinary bladder cancer	5.2e-06	8.7e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—HRAS—urinary bladder cancer	5.12e-06	8.56e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	5.09e-06	8.51e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—TP53—urinary bladder cancer	4.87e-06	8.14e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—PTEN—urinary bladder cancer	4.71e-06	7.88e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—HRAS—urinary bladder cancer	4.66e-06	7.79e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—EP300—urinary bladder cancer	4.49e-06	7.51e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	4.17e-06	6.97e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—PTEN—urinary bladder cancer	3.64e-06	6.08e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—EP300—urinary bladder cancer	3.47e-06	5.8e-05	CbGpPWpGaD
